Hot of the Press August 2024

We have collated some great articles and material published over the last month. Click on the links below to read the  abstract or download the full paper.

Anatomy / Physiology /Pathophysiology

Molecular pathophysiology of secondary lymphedema

Sang-Oh Lee, Il-Kug Kim. Front Cell Dev Biol. 2024 Jul 8.

Download full paper

New Insights into the Pathophysiology of Primary and Secondary Lymphedema: Histopathological Studies on Human Lymphatic Collecting Vessels - click for abstract

New Insights into the Pathophysiology of Primary and Secondary Lymphedema: Histopathological Studies on Human Lymphatic Collecting Vessels

Barone V, Borghini A, Tedone Clemente E, Aglianò M, Gabriele G, Gennaro P, Weber E. Lymphat Res Biol. 2020 Jul 20

Lymphedema is characterized by an accumulation of interstitial fluids due to inefficient lymphatic drainage. Primary lymphedema is a rare condition, including congenital and idiopathic forms. Secondary lymphedema is a common complication of lymph node ablation in cancer treatment. Previous studies on secondary lymphedema lymphatic vessels have shown that after an initial phase of ectasia, worsening of the disease is associated with wall thickening accompanied by a progressive loss of the endothelial marker podoplanin. Methods and Results: We enrolled 17 patients with primary and 29 patients with secondary lymphedema who underwent lymphaticovenous anastomoses surgery. Histological sections were stained with Masson’s trichrome, and immunohistochemistry was performed with antibodies to podoplanin, smooth muscle α-actin (α-SMA), and myosin heavy chain 11 (MyH11). In secondary lymphedema, we found ectasis, contraction, and sclerosis vessel types. In primary lymphedema, the majority of vessels were of the sclerosis type, with no contraction vessels. In both primary and secondary lymphedema, not all α-SMA-positive cells were also positive for MyH11, suggesting transformation into myofibroblasts. The endothelial marker podoplanin had a variable expression unrelatedly with the morphological vessel type. Conclusions: Secondary lymphedema collecting vessels included all the three types described in literature, that is, ectasis, contraction, and sclerosis, whereas in primary lymphedema, we found the ectasis and the sclerosis but not the contraction type. Some cells in the media stained positively for α-SMA but not for MyH11. These cells, possibly myofibroblasts, may contribute to collagen deposition.

Prevalence and Risk Factors

The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema

Mei Rosemary Fu, Bowen Liu, Jeanna Mary Qiu, Yuanlu Sun, Deborah Axelrod, Amber Guth, Stephanie Korth, Howard L. Kremer, Yao Wang. Ann Surg Oncol. 2024 Aug 1

Download full paper

Weight management barriers and facilitators after breast cancer in Australian women: a national survey - click for abstract

Weight management barriers and facilitators after breast cancer in Australian women: a national survey

Carolyn Ee1* , Adele Elizabeth Cave1, Dhevaksha Naidoo1, Kellie Bilinski1 and John Boyages2. BMC Women’s Health (2020) 20:140.

Background: Breast cancer is the most common cancer in women worldwide. Weight gain after breast cancer is associated with poorer health outcomes. The aim of this study was to describe how Australian breast cancer survivors are currently managing their weight.

Methods: Online cross-sectional survey open to any woman living in Australia who self-identified as having breast cancer, between November 2017 and January 2018.

Results: We received 309 responses. Most respondents described their diet as good/excellent and reported moderate-high levels of weight self-efficacy. Despite this, the proportion of overweight/obesity increased from 47% at time of diagnosis to 67% at time of survey. More than three quarters of respondents did not receive any advice on weight gain prevention at the time of diagnosis. 39% of women reported being less active after cancer diagnosis, and and few weight loss interventions were perceived to be effective. Facilitators were structured exercise programs, prescribed diets, and accountability to someone else, while commonly cited barriers were lack of motivation/willpower, fatigue, and difficulty maintaining weight. Women who cited fatigue as a barrier were almost twice as likely to be doing low levels of physical activity (PA) or no PA than women who did not cite fatigue as a barrier.

Conclusions: We report high levels of concern about weight gain after BC and significant gaps in service provision around weight gain prevention and weight management. Women with BC should be provided with support for weight gain prevention in the early survivorship phase, which should include structured PA and dietary changes in combination with behavioural change and social support. Weight gain prevention or weight loss programs should address barriers such as fatigue. More research is required on the effectiveness of diet and exercise interventions in BC survivors, particularly with regard to weight gain prevention.

Assessment

Localised Objective Characterisation Assessment of Lymphoedema (LOCAL): Using High-Frequency Ultrasound, Bioelectrical Impedance Spectroscopy and Volume to Evaluate Superficial Tissue Composition

Jennifer Sanderson, Neil Tuttle, Robyn Box, Hildegard Reul-Hirche, E-Liisa Laakso. Diagnostics (Basel). 2024 Jul 26.

Download full paper

Pitting Is Not Only a Measure of Oedema Presence: Using High-Frequency Ultrasound to Guide Pitting Test Standardisation for Assessment of Lymphoedema

Jennifer Sanderson, Neil Tuttle, Robyn Box, Hildegard Reul-Hirche, E-Liisa Laakso. Diagnostics (Basel). 2024 Jul 30. 

Download full paper

Assessment of Intraday Variations in Skin Indentation Resistance

Harvey N. Mayrovitz. Cureus. 2024 Jul 28.

Download full paper

Skin mechanical properties measured with skin elasticity measurement device in patients with lymphedema: Scoping review

Yudai Fujimoto, Yoshimi Yuri, Hironari Tamiya. Skin Res Technol. 2024 Aug 30.

Download full paper

Analysis of Different Lymphedema Assessment Tools in Women with Breast Cancer After Mastectomy - click for abstract

Analysis of Different Lymphedema Assessment Tools in Women with Breast Cancer After Mastectomy

Rocío Abalo-Núñez, Iria Da Cuña-Carrera, Alejandra Alonso-Calvete, Eva M. Lantarón-Caeiro, Mercedes Soto-González. Lymphat Res Biol. 2024 Aug 2.

Background: Lymphedema is a common complication after mastectomy in women with breast cancer. Several methods have been described to assess and diagnose lymphedema, one of the most studied being the perimeter and ultrasonography. However, the reliability of these methods and the correlation between them are still controversial. The aim of this study was to analyze the reliability of cytometry and ultrasound imaging in the assessment of lymphedema after mastectomy in women with breast cancer and to study the correlation between them. Methods and Results: A cross-sectional study was conducted in 29 women with mastectomy after breast cancer. Lymphedema in the arm was measured both with cytometry and ultrasonography. Reliability was calculated with intraclass correlation coefficient. The correlation between the two methods was carried out with the Pearson correlation coefficient. Both cytometry (M1: α = 0.999, ICC = 0.996; M2=: α = 0.998, ICC = 0.994) and ultrasonography (M1: α = 0.992, ICC = 0.976; M2=: α = 0.991, ICC = 0.973) are reliable methods to assess lymphedema in the arm. No significant correlation was found between them (p > 0.05). Conclusions: Cytometry and ultrasonography appear to be adequate for the measurement of edema in women with breast cancer after mastectomy. However, for an accurate measurement of lymphedema, these measurements should not be used interchangeably.:10.1089.0004

Management Strategies

Prevention and Treatment of Lymphedema in Breast Cancer - click for abstract

Prevention and Treatment of Lymphedema in Breast Cancer

Maureen P. McEvoy, Sheldon Feldman. Adv Surg. 2024 Sep 58.-77. Epub 2024 May 8.

Breast cancer related lymphedema (BCRL) affects many breast cancer survivors and drastically affects their quality of life. There are several surveillance methods for BCRL that are critical at early detection. Prevention of BCRL involves knowledge of alternatives to aggressive axillary surgery, avoidance of axillary surgery, and de-escalation of axillary surgery. There are also techniques to better delineate the anatomy in the axilla to avoid taking nodes that drain the upper extremity. A multidisciplinary approach with medical oncology and radiation oncology can also help avoid unnecessary surgery or radiation that can together strongly increase the risk of BCRL.:10.1016/j.yasu.2024.04.005

Complex decongestive therapy improves finger tapping score in patients with breast cancer-related lymphedema- click for abstract

Complex decongestive therapy improves finger tapping score in patients with breast cancer-related lymphedema

Evrim Gökçe, Cansu Şahbaz Pirinççi, Fikret Arı, Meltem Dalyan. Support Care Cancer. 2024 Jul 19.

PURPOSE: Breast cancer-related lymphedema (BCRL) impairs upper limb function and cognitive performance. This study aimed to evaluate the effects of fifteen sessions of complex decongestive therapy (CDT) on fine motor performance and information processing speed in women with BCRL.
METHODS: Thirty-eight women with BCRL (54.97 ± 10.78 years) were recruited in the study. Participants either received five times weekly CDT consisting of manual lymphatic drainage, skin care, compression bandaging, and remedial exercises (n = 19) or served as a wait-list control group (n = 19). We used the Finger Tapping Task to assess fine motor performance and the Digit Symbol Substitution Test to assess information processing speed. ANCOVA was performed to analyze the effect of CDT on the dependent variables, adjusting for covariates and baseline values.
RESULTS: CDT significantly improved finger tapping score (p < 0.001) compared to the wait-list to the control group, whereas information processing speed did not significantly change (p = 0.673).
CONCLUSION: The findings suggest that CDT is an effective conservative therapeutic approach to improve upper extremity fine motor function in women with BCRL. Future studies are needed to investigate the effect of CDT on different cognitive domains.:10.1007

Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial - click for abstract

Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial

Jéssica Malena Pedro da Silva, Raul Denner Duarte Araújo, Suzana Sales de Aguiar, Erica Alves Nogueira Fabro, Marcus Vinicius de Mello Pinto, Luiz Claudio Santos Thuler, Anke Bergmann. Clin Rehabil. 2024 Aug 9:2692 155 24.

OBJECTIVE: To evaluate efficacy, safety, and adherence to using adjustable compression wraps (ACWs) for upper limb volume control in women with breast cancer-related lymphedema.
DESIGN AND SETTING: Randomized controlled trial at a reference hospital for breast cancer treatment in Brazil.
PARTICIPANTS: Women in control phase of the breast cancer-related lymphedema.
INTERVENTIONS: Compared use of ACWs versus compressive mesh.
MAIN MEASURES: Evaluated before treatment, at 30 days, and 6 months after initiating therapy. The primary outcome was the change in excess limb volume. Secondary outcomes included adherence, incidence of adverse events, functionality, quality of life, and hand grip. Statistical analysis involved calculating the effect size (ES) with a 95% confidence interval.
RESULTS: Were included 71 women with mean excess limb volume of 321.79 mL (±194.98). In the 30-day analysis (Time 1), a reduction of 37.6 mL in volume was observed only in the ACW group (p = .041, ES 0.20), with improved functionality (p = .013, ES 0.22). In the six months analysis (Time 2), the compressive mesh group increased by 2.48% in volume (p = .023, ES 0.26) and demonstrated improvement functionality (p = .036, ES 0.27). Mild adverse events and satisfactory adherence were observed. However, in the intergroup comparison, no statistically significant difference was observed for any evaluated outcome-excess volume, incidence of adverse events, adherence, hand grip, quality of life, and functionality between the groups (p > .05) at both times.
CONCLUSIONS: Both compression therapies achieved satisfactory adherence, were safe, effective and equivalent for controlling limb volume in breast cancer-related lymphedema.:10.1177/02692155241270921

Accuracy of consumer-based activity trackers to measure and coach patients with lower limb lymphoedema

Astrid Blondeel, Nele Devoogdt, Anne Asnong, Inge Geraerts, An De Groef, An-Kathleen Heroes, Charlotte Van Calster, Thierry Troosters, Heleen Demeyer, Pieter Ginis, Tessa De Vrieze. PLoS One. 2024 Jul 18.

Download full paper

Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program

Fardeen Bhimani, Maureen McEvoy, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Arianna Cavalli, Liane Obaid, Carolyn Rachofsky, Shani Fruchter, Sheldon Feldman. Front Oncol. 2024 Jul 16

Download full paper

Evidence for the clinical effectiveness of decongestive lymphoedema treatment for breast cancer-related arm lymphoedema, a systematic review

Eunice Jeffs, Emma Ream, Cath Taylor, Arnie Purushotham, Debra Bick. Support Care Cancer. 2024 Aug 2

Download full paper

Lymphedema self-management mobile application with nurse support for post breast cancer surgery survivors: description of the design process and prototype evaluation

Mehrvash Hemati, Mozhgan Rivaz, Zahra Khademian. BMC Cancer. 2024 Aug 8. 

Download full paper

The effects of ACSM-based exercise on breast cancer-related lymphoedema: a systematic review and meta-analysis

Biqing Luan, Zhiqiang Li, Qizhi Yang, Zhihui Xu, Yaqin Chen, Meiting Wang, Wenlin Chen, Fei Ge. Front Physiol. 2024 Jul 23.

Download full paper